JIC
COLL icon

Johnson Investment Counsel’s Collegium Pharmaceutical COLL Stock Holding History

Johnson Investment Counsel’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5,157
Closed -$239K – 827
2025
Q4 		$239K Buy
+5,157
New +$216K ﹤0.01% 734
2024
Q4 		– Sell
-6,436
Closed -$249K – 799
2024
Q3 		$249K Hold
6,436
– – ﹤0.01% 699
2024
Q2 		$207K Sell
6,436
-886
-12% -$30.7K ﹤0.01% 711
2024
Q1 		$284K Sell
7,322
-1,015
-12% -$35.5K ﹤0.01% 622
2023
Q4 		$257K Buy
+8,337
New +$209K ﹤0.01% 620
2023
Q3 		– Sell
-9,512
Closed -$204K – 689
2023
Q2 		$204K Sell
9,512
-686
-7% -$15.6K ﹤0.01% 637
2023
Q1 		$245K Sell
10,198
-96,988
-90% -$2.57M ﹤0.01% 590
2022
Q4 		$2.49M Sell
107,186
-19,954
-16% -$402K 0.03% 206
2022
Q3 		$2.04M Buy
127,140
+1,507
+1% +$26.6K 0.03% 214
2022
Q2 		$2.23M Sell
125,633
-1,712
-1% -$28.8K 0.03% 205
2022
Q1 		$2.59M Buy
127,345
+1,520
+1% +$28.7K 0.03% 202
2021
Q4 		$2.35M Buy
125,825
+1,243
+1% +$24.2K 0.03% 217
2021
Q3 		$2.46M Buy
124,582
+33,813
+37% +$731K 0.03% 197
2021
Q2 		$2.15M Sell
90,769
-172
-0.2% -$3.97K 0.03% 207
2021
Q1 		$2.15M Buy
90,941
+5,581
+7% +$133K 0.03% 202
2020
Q4 		$1.71M Buy
85,360
+1,350
+2% +$26.4K 0.03% 216
2020
Q3 		$1.75M Buy
84,010
+26,808
+47% +$484K 0.03% 198
2020
Q2 		$1M Buy
+57,202
New +$1.12M 0.02% 282

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Johnson Investment Counsel's COLL Position: Q1 2026 in Review

Johnson Investment Counsel sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 5,157 shares — an estimated $239K sold.

Johnson Investment Counsel first reported a position in COLL in Q2 2020 and held it in 18 quarters. The position peaked at $2.59M in Q1 2022. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Johnson Investment Counsel reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Johnson Investment Counsel sold 5,157 Collegium Pharmaceutical shares in Q1 2026, an estimated $239K.
  • Johnson Investment Counsel first reported a position in Collegium Pharmaceutical in Q2 2020 and held it in 18 quarters.
  • Johnson Investment Counsel's Collegium Pharmaceutical position peaked at $2.59M in Q1 2022.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Johnson Investment Counsel's 13F filing for Q1 2026, filed 4 May 2026.